GLOBAL BLOOD PLASMA MARKET 2019-2027

Lifesciences | Diagnostic & Biotechnology

GLOBAL BLOOD PLASMA MARKET 2019-2027

Market By Blood Type, Application, End-users And Geography | Forecast 2019-2027

Request Free Sample

Request Custom Report

Request Custom Report

Enquire before buying

Enquire Before Buying

According to Triton, the global blood plasma market is expected to display a positive market trend over the forecast period of 2019-2027, exhibiting a CAGR of 6.13%. The market was assessed to be worth $18716.95 million in the year 2018 and is predicted to generate a revenue of approximately $32128.56 million by the year 2027.

Blood plasma, also known as plasma, is the liquid section of blood. It plays an essential role in delivering blood cells within the body and also helps in excreting waste products. This makes the blood plasma an extracellular matrix of the blood cells. Blood plasma makes up around 55% of the total blood volume of the body. It forms the intravascular fluid part of the extracellular fluid. It mostly consists of water i.e. up to 95% by volume and consists of dissolved proteins of about 6-8% (which mainly includes fibrinogen, globulins and serum albumins), clotting factors, glucose, electrolytes (Mg2+, Ca2+, Na+, etc.), hormones, and carbon dioxide (as plasma is a vital channel for the transportation of excretory products and oxygen). 

Out of all the plasma components, immunoglobulins are used most extensively for treating various diseases and their increasing demand is the key booster for the global blood plasma market. Blood plasma also functions as the body’s protein reserve. It has an essential role in an intravascular osmotic effect that helps in keeping the electrolytes balanced and also in protecting the body against infections and other blood disorders. Plasma enables to distribute heat throughout the human body and also helps in maintaining homeostasis or biological stability, including acid-base balance in the blood and body.

Due to the emerging incidences of primary, as well as secondary immune-deficiencies, exploring the potential of blood plasma in the large-scale treatment of immunocompromised patients becomes essential. A rise in the cases of hemophilia A, hemophilia B, von Willebrand disease and other bleeding disorders has brought in a better understanding of blood plasma and the capability of blood plasma therapies in chronic disease management. The global blood plasma market is expected to achieve significant growth during the forecast period, primarily due to high demand by a large number of patients with hardly any alternative therapeutic approach.

Within this report from Triton, the key insights regarding the industry have been discussed. Also, the clinical guidelines, regulations in plasma therapeutics, the regulatory outlook, Porter’s five force analysis, market trends and patent outlook have been studied for the blood plasma market. 

The key drivers like expansion in indication into new therapeutic areas and approval of immunoglobulin-centered therapies are boosting the market globally. Furthermore, the industry is facing market restraints like high costs of blood plasma treatments and easy availability of recombinant plasma, which are expected to obstruct the market growth over the forecasting years.

The key opportunities like the increasing public cognizance, rise in plasma products and the increasing occurrences of hemophilia are leveraging the industry to reach towards the estimated growth. However, the spread of pathogenic contaminants and high regulations are some of the challenges faced by the market and the companies.

The geographies covered in the global blood plasma market are:

•    North America: the United States and Canada

•    Europe: United Kingdom, Germany, France, Italy, Spain, Russia and Rest of Europe

•    Asia-Pacific: China, Japan, India, South Korea, ASEAN countries, Australia & New Zealand and Rest of Asia-Pacific

•   Latin America: Brazil, Mexico and Rest of Latin America

•    The Middle East and Africa: United Arab Emirates, Turkey, Saudi Arabia, South Africa and Rest of the Middle East & Africa

The global blood plasma market has been segmented as follows:

•    By Blood Type:

O    Albumin

O    Immunoglobulin

•    Intravenous immunoglobulin

•    Subcutaneous immunoglobulin

•    Other immunoglobulin types

O    Coagulation factor concentrates

O    Hyperimmune

O    Other plasma fractionation products

•    By Application:

O    Oncology 

O    Hematology

O    Transplantation

O    Rheumatology

O    Neurology

O    Immunology

O    Pulmonology

O    Other applications

•    By End-Users: 

O    Academic institutions

O    Research laboratories

O    Hospitals and clinics

The major players that have been studied in the market are Shire Plc, Arthrex, Octapharma AG, Baxter International, Inc., Grifols International S.A., Biotest AG, CSL Ltd., ADMA Biologics, Inc., China Biologic Products, Inc., General Electric, Co. and Cerus Corp.

The strategic analysis for each of these companies in blood plasma market has been covered in detail. The market share of the company helps in diving into the information about the market players and their hold in the market.

Related Reports

ASIA PACIFIC AESTHETIC LASER MARKET 2019-2027
Lifesciences

ASIA PACIFIC AESTHETIC LASER MARKET 2019-2027

Market By Type, Application, E ..

VIEW REPORT
ASIA PACIFIC BIOCHIPS MARKET 2019-2027
Lifesciences

ASIA PACIFIC BIOCHIPS MARKET 2019-2027

Market By Type, Substrate Mate ..

VIEW REPORT
ASIA PACIFIC BIOPSY DEVICE MARKET 2019-2027
Lifesciences

ASIA PACIFIC BIOPSY DEVICE MARKET 2019-2027

Market By Device Type, Therape ..

VIEW REPORT
ASIA PACIFIC DNA VACCINES MARKET 2019-2027
Lifesciences

ASIA PACIFIC DNA VACCINES MARKET 2019-2027

Market By Type, Application, T ..

VIEW REPORT
ASIA-PACIFIC 3D CELL CULTURE MARKET 2019-2027
Lifesciences

ASIA-PACIFIC 3D CELL CULTURE MARKET 2019-2027

Market By Technology, Applicat ..

VIEW REPORT
ASIA-PACIFIC AIRWAY CLEARANCE SYSTEM MARKET 2019-2028
Lifesciences

ASIA-PACIFIC AIRWAY CLEARANCE SYSTEM MARKET 2019-2028

Market By Application, Type, E ..

VIEW REPORT

Table of Content

1.    GLOBAL BLOOD PLASMA MARKET - SUMMARY

2.    INDUSTRY OUTLOOK

2.1. MARKET DEFINITION

2.2. PORTER’S FIVE FORCES OUTLOOK

2.2.1.   THREAT OF NEW ENTRANTS

2.2.2.   THREAT OF SUBSTITUTES

2.2.3.   BARGAINING POWER OF BUYERS

2.2.4.   BARGAINING POWER OF SUPPLIERS

2.2.5.   THREAT OF RIVALRY

2.3. VENDOR SCORECARD

2.4. CLINICAL GUIDELINES

2.5. REGULATION IN THE PLASMA THERAPEUTICS

2.6. KEY INSIGHTS

2.7. REGULATORY OUTLOOK

2.8. MARKET TRENDS

2.9. PATENT OUTLOOK

2.10.            MARKET DRIVERS

2.10.1.                EXPANSION IN INDICATION FOR NEW THERAPEUTIC AREAS

2.10.2.                APPROVAL OF IMMUNOGLOBULIN-CENTERED THERAPIES

2.10.3.                SURGE IN THE HEMOPHILIA TREATMENT

2.10.4.                RISE IN THE ELDERLY POPULATION

2.11.            MARKET RESTRAINTS

2.11.1.                HIGH COSTS OF BLOOD PLASMA TREATMENTS

2.11.2.                EASY AVAILABILITY OF RECOMBINANT PLASMA

2.12.            MARKET OPPORTUNITIES

2.12.1.                INCREASING PUBLIC COGNIZANCE

2.12.2.                RISE IN THE PLASMA-DERIVED PRODUCTS OPPORTUNITIES

2.12.3.                INCREASING OCCURRENCE OF HEMOPHILIA

2.13.            MARKET CHALLENGES

2.13.1.                SPREAD OF PATHOGENIC CONTAMINANTS

2.13.2.                HIGH REGULATIONS IN THE MARKET

2.14.            BLOOD PLASMA INDUSTRY BY MODE OF DELIVERY

2.14.1.                INFUSION SOLUTIONS

2.14.2.                GELS

2.14.3.                SPRAYS

2.14.4.                BIOMEDICAL SEALANTS

3.    BLOOD PLASMA MARKET OUTLOOK - BY BLOOD TYPE

3.1. ALBUMIN

3.2. IMMUNOGLOBULIN

3.2.1.   INTRAVENOUS IMMUNOGLOBULIN

3.2.2.   SUBCUTANEOUS IMMUNOGLOBULIN

3.2.3.   OTHER IMMUNOGLOBULIN TYPE

3.3. COAGULATION FACTOR CONCENTRATES

3.4. HYPERIMMUNES

3.5. OTHER PLASMA FRACTIONATION PRODUCTS

4.    BLOOD PLASMA MARKET OUTLOOK - BY APPLICATION

4.1. ONCOLOGY

4.2. HEMATOLOGY

4.3. TRANSPLANTATION

4.4. RHEUMATOLOGY

4.5. NEUROLOGY

4.6. IMMUNOLOGY

4.7. PULMONOLOGY

4.8. OTHER APPLICATIONS

5.    BLOOD PLASMA MARKET OUTLOOK - BY END-USER

5.1. ACADEMIC INSTITUTIONS

5.2. RESEARCH LABORATORIES

5.3. HOSPITALS AND CLINICS

6.    BLOOD PLASMA MARKET - REGIONAL OUTLOOK

6.1. NORTH AMERICA

6.1.1.   MARKET BY BLOOD TYPE

6.1.2.   MARKET BY END-USER

6.1.3.   MARKET BY APPLICATION

6.1.4.   COUNTRY ANALYSIS

6.1.4.1.      THE UNITED STATES

6.1.4.2.      CANADA

6.2. EUROPE

6.2.1.   MARKET BY BLOOD TYPE

6.2.2.   MARKET BY END-USER

6.2.3.   MARKET BY APPLICATION

6.2.4.   COUNTRY ANALYSIS

6.2.4.1.      FRANCE

6.2.4.2.      GERMANY

6.2.4.3.      THE UNITED KINGDOM

6.2.4.4.      ITALY

6.2.4.5.      SPAIN

6.2.4.6.      RUSSIA

6.2.4.7.      REST OF EUROPE

6.3. ASIA-PACIFIC

6.3.1.   MARKET BY BLOOD TYPE

6.3.2.   MARKET BY END-USER

6.3.3.   MARKET BY APPLICATION

6.3.4.   COUNTRY ANALYSIS

6.3.4.1.      JAPAN

6.3.4.2.      CHINA

6.3.4.3.      AUSTRALIA & NEW ZEALAND

6.3.4.4.      INDIA

6.3.4.5.      SOUTH KOREA

6.3.4.6.      ASEAN COUNTRIES

6.3.4.7.      REST OF ASIA-PACIFIC

6.4. LATIN AMERICA

6.4.1.   MARKET BY BLOOD TYPE

6.4.2.   MARKET BY END-USER

6.4.3.   MARKET BY APPLICATION

6.4.4.   COUNTRY ANALYSIS

6.4.4.1.      BRAZIL

6.4.4.2.      MEXICO

6.4.4.3.      REST OF LATIN AMERICA

6.5. MIDDLE EAST AND AFRICA

6.5.1.   MARKET BY BLOOD TYPE

6.5.2.   MARKET BY END-USER

6.5.3.   MARKET BY APPLICATION

6.5.4.   COUNTRY ANALYSIS

6.5.4.1.      SAUDI ARABIA

6.5.4.2.      TURKEY

6.5.4.3.      THE UNITED ARAB EMIRATES

6.5.4.4.      SOUTH AFRICA

6.5.4.5.      REST OF MIDDLE EAST & AFRICA

7.    COMPANY PROFILES

7.1. SHIRE PLC

7.2. ARTHREX

7.3. OCTAPHARMA AG

7.4. BAXTER INTERNATIONAL, INC.

7.5. GRIFOLS INTERNATIONAL S.A.

7.6. BIOTEST AG

7.7. CSL LTD.

7.8. ADMA BIOLOGICS, INC.

7.9. CHINA BIOLOGIC PRODUCTS, INC.

7.10.            GENERAL ELECTRIC CO.

7.11.            CERUS CORP.

8.    METHODOLOGY & SCOPE

8.1. RESEARCH SCOPE

8.2. SOURCES OF DATA

8.3. RESEARCH METHODOLOGY

List of table

TABLE 1        GLOBAL BLOOD PLASMA MARKET BY REGION 2019-2027 ($ MILLION)          

TABLE 2        BLOOD PLASMA COMPONENTS          

TABLE 3        BLOOD PLASMA PRODUCTS NUMBER OF PATENTS ISSUED 2014-2016       

TABLE 4        GLOBAL BLOOD PLASMA MARKET BY BLOOD TYPE 2019-2027 ($ MILLION) 

TABLE 5        GLOBAL BLOOD PLASMA MARKET IN IMMUNOGLOBULIN BY TYPES 2019-2027 ($ MILLION) 

TABLE 6        PROTEASE INHIBITORS USED IN THE HIV INFECTION TREATMENT   

TABLE 7        GLOBAL BLOOD PLASMA MARKET BY APPLICATION 2019-2027 ($ MILLION)

TABLE 8        GLOBAL BLOOD PLASMA MARKET BY END-USER 2019-2027 ($ MILLION)     

TABLE 9        GLOBAL BLOOD PLASMA MARKET BY REGION 2019-2027 ($ MILLION)          

TABLE 10      NORTH AMERICA BLOOD PLASMA MARKET BY BLOOD TYPE 2019-2027 ($ MILLION)      

TABLE 11      NORTH AMERICA BLOOD PLASMA MARKET BY END-USER 2019-2027 ($ MILLION)      

TABLE 12      NORTH AMERICA BLOOD PLASMA MARKET BY APPLICATION 2019-2027 ($ MILLION)      

TABLE 13      NORTH AMERICA BLOOD PLASMA MARKET BY COUNTRY 2019-2027 ($ MILLION)      

TABLE 14      EUROPE BLOOD PLASMA MARKET BY BLOOD TYPE 2019-2027 ($ MILLION)

TABLE 15      EUROPE BLOOD PLASMA MARKET BY END-USER 2019-2027 ($ MILLION)    

TABLE 16      EUROPE BLOOD PLASMA MARKET BY APPLICATION 2019-2027 ($ MILLION)           

TABLE 17      EUROPE BLOOD PLASMA MARKET BY COUNTRY 2019-2027 ($ MILLION)      

TABLE 18      ASIA-PACIFIC BLOOD PLASMA MARKET BY BLOOD TYPE 2019-2027 ($ MILLION)      

TABLE 19      ASIA-PACIFIC BLOOD PLASMA MARKET BY END-USER 2019-2027 ($ MILLION)           

TABLE 20      ASIA-PACIFIC BLOOD PLASMA MARKET BY APPLICATION 2019-2027 ($ MILLION)      

TABLE 21      ASIA-PACIFIC BLOOD PLASMA MARKET BY COUNTRY 2019-2027 ($ MILLION)           

TABLE 22      MIDDLE EAST AND AFRICA BLOOD PLASMA MARKET BY BLOOD TYPE 2019-2027 ($ MILLION)   

TABLE 23      MIDDLE EAST AND AFRICA BLOOD PLASMA MARKET BY END-USER 2019-2027 ($ MILLION) 

TABLE 24      MIDDLE EAST AND AFRICA BLOOD PLASMA MARKET BY APPLICATION 2019-2027 ($ MILLION)   

TABLE 25      MIDDLE EAST AND AFRICA BLOOD PLASMA MARKET BY COUNTRY 2019-2027 ($ MILLION) 

TABLE 26      LATIN AMERICA BLOOD PLASMA MARKET BY BLOOD TYPE 2019-2027 ($ MILLION)      

TABLE 27      LATIN AMERICA BLOOD PLASMA MARKET BY END-USER 2019-2027 ($ MILLION)           

TABLE 28      LATIN AMERICA BLOOD PLASMA MARKET BY APPLICATION 2019-2027 ($ MILLION)      

TABLE 29      LATIN AMERICA BLOOD PLASMA MARKET BY COUNTRY 2019-2027 ($ MILLION)            

List of Figures

FIGURE 1      GLOBAL BLOOD PLASMA MARKET 2019-2027 ($ MILLION)

FIGURE 2      BLOOD PLASMA PRODUCTS PATENTS SHARES BY COUNTRY 2014-2016 (%)

FIGURE 3      IMMUNOGLOBULIN INFUSIONS SIDE-EFFECTS

FIGURE 4      ROLE OF FIBRIN SEALANT IN COAGULATION CASCADE

FIGURE 5      GLOBAL BLOOD PLASMA MARKET IN ALBUMIN 2019-2027 ($ MILLION)

FIGURE 6      GLOBAL BLOOD PLASMA MARKET IN IMMUNOGLOBULIN 2019-2027 ($ MILLION)

FIGURE 7      GLOBAL IMMUNOGLOBULIN MARKET IN INTRAVENOUS IMMUNOGLOBULIN 2019-2027 ($ MILLION)

FIGURE 8      GLOBAL IMMUNOGLOBULIN MARKET IN SUBCUTANEOUS IMMUNOGLOBULIN 2019-2027 ($ MILLION)

FIGURE 9      GLOBAL IMMUNOGLOBULIN MARKET IN OTHER IMMUNOGLOBULIN TYPE 2019-2027 ($ MILLION)

FIGURE 10   GLOBAL BLOOD PLASMA MARKET IN COAGULATION FACTOR CONCENTRATES 2019-2027 ($ MILLION)

FIGURE 11   HYPERIMMUNES ISOLATION PROCESS

FIGURE 12   GLOBAL BLOOD PLASMA MARKET IN HYPERIMMUNES 2019-2027 ($ MILLION)

FIGURE 13   GLOBAL BLOOD PLASMA MARKET IN OTHER PLASMA FRACTIONATION PRODUCTS 2019-2027 ($ MILLION)

FIGURE 14   GLOBAL BLOOD PLASMA MARKET IN ONCOLOGY 2019-2027 ($ MILLION)

FIGURE 15   GLOBAL BLOOD PLASMA MARKET IN HEMATOLOGY 2019-2027 ($ MILLION)

FIGURE 16   GLOBAL BLOOD PLASMA MARKET IN TRANSPLANTATION 2019-2027 ($ MILLION)

FIGURE 17   LUPUS INFECTION SYMPTOMS

FIGURE 18   GLOBAL BLOOD PLASMA MARKET IN RHEUMATOLOGY 2019-2027 ($ MILLION)

FIGURE 19   GLOBAL BLOOD PLASMA MARKET IN NEUROLOGY 2019-2027 ($ MILLION)

FIGURE 20   GLOBAL BLOOD PLASMA MARKET IN PULMONOLOGY 2019-2027 ($ MILLION)

FIGURE 21   GLOBAL BLOOD PLASMA MARKET IN IMMUNOLOGY 2019-2027 ($ MILLION)

FIGURE 22   GLOBAL BLOOD PLASMA MARKET IN OTHER APPLICATIONS 2019-2027 ($ MILLION)

FIGURE 23   GLOBAL BLOOD PLASMA MARKET IN ACADEMIC INSTITUTIONS 2019-2027 ($ MILLION)

FIGURE 24   GLOBAL BLOOD PLASMA MARKET IN RESEARCH LABORATORIES 2019-2027 ($ MILLION)

FIGURE 25   GLOBAL BLOOD PLASMA MARKET IN HOSPITALS AND CLINICS 2019-2027 ($ MILLION)

FIGURE 26   THE UNITED STATES BLOOD PLASMA MARKET 2019-2027 ($ MILLION)

FIGURE 27   CANADA BLOOD PLASMA MARKET 2019-2027 ($ MILLION)

FIGURE 28   FRANCE BLOOD PLASMA MARKET 2019-2027 ($ MILLION)

FIGURE 29   GERMANY BLOOD PLASMA MARKET 2019-2027 ($ MILLION)

FIGURE 30   THE UNITED KINGDOM BLOOD PLASMA MARKET 2019-2027 ($ MILLION)

FIGURE 31   ITALY BLOOD PLASMA MARKET 2019-2027 ($ MILLION)

FIGURE 32   SPAIN BLOOD PLASMA MARKET 2019-2027 ($ MILLION)

FIGURE 33   RUSSIA BLOOD PLASMA MARKET 2019-2027 ($ MILLION)

FIGURE 34   REST OF EUROPE BLOOD PLASMA MARKET 2019-2027 ($ MILLION)

FIGURE 35   JAPAN BLOOD PLASMA MARKET 2019-2027 ($ MILLION)

FIGURE 36   CHINA BLOOD PLASMA MARKET 2019-2027 ($ MILLION)

FIGURE 37   AUSTRALIA & NEW ZEALAND BLOOD PLASMA MARKET 2019-2027 ($ MILLION)

FIGURE 38   INDIA BLOOD PLASMA MARKET 2019-2027 ($ MILLION)

FIGURE 39   SOUTH KOREA BLOOD PLASMA MARKET 2019-2027 ($ MILLION)

FIGURE 40   ASEAN COUNTRIES BLOOD PLASMA MARKET 2019-2027 ($ MILLION)

FIGURE 41   REST OF ASIA-PACIFIC BLOOD PLASMA MARKET 2019-2027 ($ MILLION)

FIGURE 42   BRAZIL BLOOD PLASMA MARKET 2019-2027 ($ MILLION)

FIGURE 43   MEXICO BLOOD PLASMA MARKET 2019-2027 ($ MILLION)

FIGURE 44   REST OF LATIN AMERICA BLOOD PLASMA MARKET 2019-2027 ($ MILLION)

FIGURE 45   SAUDI ARABIA BLOOD PLASMA MARKET 2019-2027 ($ MILLION)

FIGURE 46   TURKEY BLOOD PLASMA MARKET 2019-2027 ($ MILLION)

FIGURE 47   THE UNITED ARAB EMIRATES BLOOD PLASMA MARKET 2019-2027 ($ MILLION)

FIGURE 48   SOUTH AFRICA BLOOD PLASMA MARKET 2019-2027 ($ MILLION)

FIGURE 49   REST OF MIDDLE EAST & AFRICA BLOOD PLASMA MARKET 2019-2027 ($ MILLION)

Purchase Options

  • Licence Type
  • Price
  • User/Sharing
  • Printing
  • Delivery Formats
  • Free customization (Pre-sale)
  • Analyst hour support (Post Sale)
  • Customized notification for newly published report
  • Free report on update (within 180 days)

Single User PDF

$2,750.00

  • User/Sharing
  • Restricted to one authorized user
  • Printing
  • Not printable
  • Delivery Formats
  • Pdf
  • Free customization (Pre-sale)
  • 10% Free customization
  • Analyst hour support (Post Sale)
  • 3 hours
  • Customized notification (newly published)
  • Free report on update (within 180 days)

Enterprise Online/PDF

$4,000.00

  • User/Sharing
  • Unlimited
  • Printing
  • Unlimited
  • Delivery Formats
  • Pdf and market estimation excel
  • Free customization (Pre-sale)
  • 20% Free customization
  • Analyst hour support (Post Sale)
  • 8 hour
  • Customized notification (newly published)
  • Free report on update (within 180 days)

Request free Sample

SUBMIT REQUEST
Request Custom Report

Request Custom Report

Enquire before buying

Enquire Before Buying

;